Beverly Hills Private Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61M Sell
14,225
-8,797
-38% -$2.05M 0.69% 45
2026
Q1
$5.63M Sell
23,022
-196
-0.8% -$45.7K 0.94% 27
2025
Q4
$4.81M Sell
23,218
-331
-1% -$65.5K 0.82% 29
2025
Q3
$4.37M Sell
23,549
-1,434
-6% -$246K 0.77% 30
2025
Q2
$3.82M Sell
24,983
-536
-2% -$82.4K 0.72% 32
2025
Q1
$4.23M Buy
25,519
+210
+0.8% +$32.9K 0.84% 28
2024
Q4
$3.66M Sell
25,309
-857
-3% -$133K 0.74% 30
2024
Q3
$4.24M Sell
26,166
-1,886
-7% -$300K 0.86% 24
2024
Q2
$4.1M Sell
28,052
-318
-1% -$47.3K 0.89% 24
2024
Q1
$4.49M Buy
28,370
+906
+3% +$144K 1.04% 19
2023
Q4
$4.3M Sell
27,464
-2,331
-8% -$357K 1.12% 18
2023
Q3
$4.64M Sell
29,795
-24,567
-45% -$4.05M 1.38% 11
2023
Q2
$9.19M Buy
54,362
+21,321
+65% +$3.44M 1.51% 9
2023
Q1
$5.12M Buy
33,041
+11,695
+55% +$1.89M 1.59% 8
2022
Q4
$3.77M Buy
+21,346
New +$3.69M 1.65% 9

Other funds holding JNJ

Beverly Hills Private Wealth's JNJ Position: Q2 2026 in Review

Beverly Hills Private Wealth reduced its Johnson & Johnson (JNJ) stake by 38% in Q2 2026, selling an estimated $2.05M and leaving 14,225 shares worth $3.61M. The position accounts for 0.69% of the portfolio, ranked #45.

Beverly Hills Private Wealth first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $9.19M in Q2 2023. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Beverly Hills Private Wealth held 14,225 shares of Johnson & Johnson worth $3.61M as of Q2 2026.
  • Beverly Hills Private Wealth sold 8,797 Johnson & Johnson shares in Q2 2026, an estimated $2.05M.
  • Johnson & Johnson made up 0.69% of Beverly Hills Private Wealth's portfolio in Q2 2026, its #45 holding.
  • Beverly Hills Private Wealth first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Beverly Hills Private Wealth's Johnson & Johnson position peaked at $9.19M in Q2 2023.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Beverly Hills Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.